Status:
COMPLETED
A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Nephrolithiasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Flexible ureteroscopy is characterized as first-line therapy for the treatment of renal stones \< 2 cm in size. This involves passing a flexible endoscope into the renal pelvis through the urethra, bl...
Detailed Description
There is ongoing debate on the optimal means of laser stone fragmentation, and Moses technology is the latest advancement to raise questions regarding clinical utility. Initial preclinical studies dem...
Eligibility Criteria
Inclusion
- Solitary renal stone 8 to 20 mm in size or in the case of multiple stones the conglomerate diameter (additive maximal diameter of all stones on axial imaging of computed tomography) of 8-20 mm is required
- Must be a suitable operative candidate for flexible ureteroscopy per urologic guidelines
- Must be 18 years or older
- Must be able to give consent
Exclusion
- Concomitant stones in the ureter
- Prior ipsilateral upper urinary tract reconstructive procedures or history of ipsilateral ureteral stricture
- Prior radiotherapy to the abdomen or pelvis
- Neurogenic bladder or spinal cord injury
- Pregnancy
- Untreated UTI
Key Trial Info
Start Date :
January 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT04505956
Start Date
January 13 2021
End Date
December 1 2023
Last Update
October 9 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Phoenix, Arizona, United States, 85054
2
University of California San Diego
San Diego, California, United States, 92103
3
Columbia University
New York, New York, United States, 10032
4
Duke University Medical Center
Durham, North Carolina, United States, 27710